Melding Regulatory, Pharmaceutical Industry, and U.S. Payer Perspectives on Improving Approaches to Heterogeneity of Treatment Effect in Research and Practice-Reference-Cited by-同舟云学术

Melding Regulatory, Pharmaceutical Industry, and U.S. Payer Perspectives on Improving Approaches to Heterogeneity of Treatment Effect in Research and Practice

Published:2013-09 Issue:6 Volume:16 Page:S10-S15
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Willke Richard J.,Crown William,del Aguila Michael,Cziraky Mark J.,Khan Zeba M.,Migliori Richard

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference34 articles.

1. Priorities for Personalized Medicine,2008

2. Evidence-based medicine, heterogeneity of treatment effects, and the trouble with averages;Kravitz;Milbank Q,2004

3. Redekop K, Mladsi D. The faces of personalized medicine: a framework for understanding its meaning and scope. Value Health 2013;16(Suppl.):S4–9

4. ISPOR Institutional Council Comparative Effectiveness Research Working Group. “Differences on differences: does perspective matter when considering heterogeneity of treatment effect?” ISPOR Forum at the ISPOR 15th Annual International Meetings, May 2011; Baltimore, MD.

5. US Food and Drug Administration. Guidance for Industry: E9 Statistical Principles for Clinical Trials. Washington, DC: U.S. Department of Health and Human Services, September 1998.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bridges to the Future: Precision Medicine Workshops in the 2023 Smart Diaspora Conference;Journal of Medical and Radiation Oncology;2023-10-01

2. An efficient and safe platform based on the tube-in-tube reactor for implementing gas-liquid processes in flow;Green Chemical Engineering;2022-12

3. Flexible on-demand cell-free protein synthesis platform based on a tube-in-tube reactor;Reaction Chemistry & Engineering;2020

4. Outlook for the Future;Translating Molecules into Medicines;2017

5. Translating Comparative Effectiveness Research Evidence to Real-World Decision Making: Some Practical Considerations;Decision Making in a World of Comparative Effectiveness Research;2017